Related Experiment Videos

Issues in the design and implementation of multicenter studies in pediatric nephrology

R J Hogg1, J Gray

  • 1Southwest Pediatric Nephrology Study Group, North Textas Hospital for Children, Dallas, Texas 75230, USA. info@spnsg.org

Blood Pressure Monitoring
|September 22, 1999
PubMed

Insights

Multicenter studies are crucial for pediatric nephrology research, especially for pediatric hypertension clinical trials. This review addresses challenges and strategies for successful multicenter trial design and execution in children.

Area of Science:

  • Pediatric Nephrology
  • Clinical Trial Design

Background:

  • Multicenter studies are increasingly recognized for studying pediatric renal diseases.
  • Previous research highlights the importance of collaborative efforts in pediatric nephrology.

Purpose of the Study:

  • To review critical issues in designing and conducting successful multicenter trials.
  • To emphasize the significance of these trials for pediatric antihypertensive medication studies.
  • To provide insights into future multicenter hypertension protocols for children and adolescents.

Main Methods:

  • Literature review of multicenter study challenges and successes.
  • Historical perspective on pediatric nephrology trials.
  • Analysis of design, communication, authorship, and financial considerations.

Main Results:

  • Identifies common difficulties in multicenter studies.
  • Discusses specific design challenges and the need for effective networking.
  • Addresses potential issues with authorship and financial reimbursement.

Conclusions:

  • Successful multicenter trials require careful planning regarding design, communication, and logistics.
  • Addressing identified challenges is key to advancing pediatric nephrology research, particularly in hypertension.
  • Recommendations are provided for future multicenter hypertension studies in pediatric populations.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...